| Absorption |
| Blood-Brain Barrier | BBB+ | 0.5441 |
| Human Intestinal Absorption | HIA+ | 0.9859 |
| Caco-2 Permeability | Caco2+ | 0.8705 |
| P-glycoprotein Substrate | Non-substrate | 0.6621 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9804 |
| Non-inhibitor | 0.9933 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9211 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9052 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7327 |
| CYP450 2D6 Substrate | Non-substrate | 0.9056 |
| CYP450 3A4 Substrate | Non-substrate | 0.7330 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9129 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.6743 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9694 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8282 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.8585 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8396 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9577 |
| Non-inhibitor | 0.9724 |
| AMES Toxicity | Non AMES toxic | 0.9696 |
| Carcinogens | Non-carcinogens | 0.8458 |
| Fish Toxicity | High FHMT | 0.7539 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.5795 |
| Honey Bee Toxicity | High HBT | 0.7173 |
| Biodegradation | Ready biodegradable | 0.7219 |
| Acute Oral Toxicity | III | 0.6729 |
| Carcinogenicity (Three-class) | Non-required | 0.8005 |